Cite
Safety and efficacy of etanercept in children with juvenile idiopathic arthritis below the age of 2 years.
MLA
Windschall, D., et al. “Safety and Efficacy of Etanercept in Children with Juvenile Idiopathic Arthritis below the Age of 2 Years.” Rheumatology International, vol. 35, no. 4, Apr. 2015, pp. 613–18. EBSCOhost, https://doi.org/10.1007/s00296-014-3125-9.
APA
Windschall, D., Müller, T., Becker, I., & Horneff, G. (2015). Safety and efficacy of etanercept in children with juvenile idiopathic arthritis below the age of 2 years. Rheumatology International, 35(4), 613–618. https://doi.org/10.1007/s00296-014-3125-9
Chicago
Windschall, D., T. Müller, I. Becker, and G. Horneff. 2015. “Safety and Efficacy of Etanercept in Children with Juvenile Idiopathic Arthritis below the Age of 2 Years.” Rheumatology International 35 (4): 613–18. doi:10.1007/s00296-014-3125-9.